Uniquely-licensed supplier of exclusive, high quality, low cost branded cannabis products via established medical clinic partnerships & UK pharmacy contracts. Poised to become a dominant leader in the UK medical cannabis sector!
• UK: Import, Distribution, Schedule 1 Narcotics, Processing, Online Medical Clinics License
• Channel Islands: Cultivation and Processing License
Seeking strategic equity partner to invest $2.8 million USD
Import and distribution of high-quality, low-cost, branded cannabis flower and oil products for UK medical cannabis patients via exclusive UK pharmacy contracts
Exclusive contracts with well-established, top ranked Canadian and global medical cannabis producers, with market proven products
Access to a large and increasing pool of medicinal cannabis patients through in-house and partner health clinics, pharmacies and other key relationships
Product launch via dedicated sales and marketing team, with first revenues in Q4 of 2023
Experienced, industry-leading international team with deep expertise in navigating global medical cannabis markets
$1M USD projected annual sales in 2023, with $10M USD sales projected in 2024
No capital required for infrastructure
All licenses in place
Turn key operation
Expansion of wholesale distribution of branded cannabis flower, oils and derivative products to the European Union and global markets via a partner facility in Ireland.
Implementation of in-house EU GMP production in the UK/Channel Islands for direct distribution into the UK and EU markets